Nuvalent Inc (NUVL)

Oct 14, 2025

Regression analysis insights on Nuvalent Inc. performanceIPO Watch & Fast Moving Market Watchlists - newser.com

Oct 14, 2025

Oct 14, 2025

Statistical indicators supporting Nuvalent Inc.’s strengthJuly 2025 Decliners & Fast Exit Strategy with Risk Control - newser.com

Oct 14, 2025

Oct 13, 2025

Nuvalent to present new data on HER2 inhibitor at cancer conference - Investing.com Nigeria

Oct 13, 2025

Oct 13, 2025

Nuvalent to present new data on HER2 inhibitor at cancer conference By Investing.com - Investing.com South Africa

Oct 13, 2025

Oct 13, 2025

Preclinical intracranial activity: Nuvalent’s NVL-330 to be presented at AACR‑NCI‑EORTC Oct 24 - Stock Titan

Oct 13, 2025

Oct 13, 2025

Will Nuvalent Inc. stock rally after Fed decisionsJuly 2025 Weekly Recap & Low Risk Investment Opportunities - newser.com

Oct 13, 2025

Oct 13, 2025

How Nuvalent Inc. stock reacts to oil pricesBond Market & Entry Point Confirmation Signals - newser.com

Oct 13, 2025

Oct 13, 2025

What moving averages say about Nuvalent Inc.Trade Exit Summary & Weekly High Potential Stock Alerts - newser.com

Oct 13, 2025

Oct 13, 2025

Custom strategy builders for tracking Nuvalent Inc.Weekly Trade Review & Verified Short-Term Plans - newser.com

Oct 13, 2025

Oct 13, 2025

Forecasting Nuvalent Inc. price range with options data2025 EndofYear Setup & Daily Growth Stock Investment Tips - newser.com

Oct 13, 2025

Oct 13, 2025

Nuvalent, Inc. (NUVL) Stock Analysis: Exploring a 32% Upside Potential with Strong Buy Ratings - DirectorsTalk Interviews

Oct 13, 2025

Oct 11, 2025

Nuvalent To Participate In The UBS 2025 Virtual Oncology Day - Barchart.com

Oct 11, 2025

Oct 10, 2025

Is Nuvalent Inc. stock bottoming outVolume Spike & Weekly Chart Analysis and Trade Guides - newser.com

Oct 10, 2025

Oct 10, 2025

Nuvalent (NASDAQ:NUVL) Earns "Sell (D-)" Rating from Weiss Ratings - MarketBeat

Oct 10, 2025

Oct 10, 2025

Can trapped investors hope for a rebound in Nuvalent Inc.July 2025 Momentum & Safe Capital Growth Trade Ideas - newser.com

Oct 10, 2025

Oct 09, 2025

Nuvalent Inc. stock trendline breakdown2025 Valuation Update & Daily Chart Pattern Signals - newser.com

Oct 09, 2025

Oct 09, 2025

Is Nuvalent Inc. showing signs of accumulationJuly 2025 Opening Moves & Low Risk Investment Opportunities - newser.com

Oct 09, 2025

Oct 09, 2025

What MACD signals say about Nuvalent Inc.Trade Entry Report & Risk Managed Investment Strategies - newser.com

Oct 09, 2025

Oct 09, 2025

Intraday pattern recognizer results for Nuvalent Inc.Quarterly Profit Report & AI Powered Market Trend Analysis - newser.com

Oct 09, 2025

Oct 09, 2025

Is Nuvalent Inc. stock a buy before product launchesMarket Trend Review & Precise Buy Zone Tips - newser.com

Oct 09, 2025

Oct 08, 2025

The Escalator: Eli Lilly, Nuvalent, Lumen Bioscience and more - Medical Marketing and Media

Oct 08, 2025

Oct 08, 2025

Nuvalent’s SWOT analysis: oncology innovator’s stock faces pivotal year By Investing.com - Investing.com South Africa

Oct 08, 2025

Oct 08, 2025

Nuvalent’s SWOT analysis: oncology innovator’s stock faces pivotal year - Investing.com

Oct 08, 2025

Oct 06, 2025

J.P. Morgan Maintains Nuvalent(NUVL.US) With Buy Rating - 富途牛牛

Oct 06, 2025

Oct 06, 2025

Nuvalent, Inc. (NUVL) Stock Analysis: Promising Biotech With 38% Upside Potential - DirectorsTalk Interviews

Oct 06, 2025

Oct 05, 2025

What to expect from Nuvalent Inc. in the next 30 daysJuly 2025 Selloffs & High Yield Equity Trading Tips - newser.com

Oct 05, 2025

Oct 05, 2025

Will Nuvalent Inc. stock outperform Dow Jones index2025 Key Lessons & AI Driven Price Predictions - newser.com

Oct 05, 2025

Oct 05, 2025

Is Nuvalent Inc. reversing from oversold territoryQuarterly Growth Report & Technical Pattern Recognition Alerts - newser.com

Oct 05, 2025

Oct 02, 2025

Analyzing net buyer seller activity in Nuvalent Inc.Quarterly Risk Review & Free Expert Approved Momentum Trade Ideas - newser.com

Oct 02, 2025

Oct 02, 2025

Nuvalent, Inc. Stock (NUVL) Opinions on Cancer Therapy Developments and Insider Sale - Quiver Quantitative

Oct 02, 2025

Oct 02, 2025

Nuvalent chief development officer Noci sells $332k in shares By Investing.com - Investing.com UK

Oct 02, 2025

Oct 01, 2025

Nuvalent CFO Balcom sells $2.3m in NUVL stock By Investing.com - Investing.com South Africa

Oct 01, 2025

Oct 01, 2025

Nuvalent chief development officer Noci sells $332k in shares - Investing.com India

Oct 01, 2025